TIAA CREF Investment Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $19.5M | Sell |
|
|||||
|
2018
Q4 | $24.5M | Sell |
|
|||||
|
2018
Q3 | $36.9M | Buy |
|
|||||
|
2018
Q2 | $17.4M | Sell |
|
|||||
|
2018
Q1 | $21.9M | Sell |
|
|||||
|
2017
Q4 | $32.4M | Buy |
|
|||||
|
2017
Q3 | $12.6M | Sell |
|
|||||
|
2017
Q2 | $40.6M | Buy |
|
|||||
|
2017
Q1 | $6.44M | Sell |
|
|||||
|
2016
Q4 | $5.07M | Sell |
|
|||||
|
2016
Q3 | $14.5K | Buy |
|
|||||
|
2016
Q2 | $10.7M | Sell |
|
|||||
|
2016
Q1 | $12.2M | Sell |
|
|||||
|
2015
Q4 | $18.9M | Sell |
|
|||||
|
2015
Q3 | $17.8M | Sell |
|
|||||
|
2015
Q2 | $49.5M | Buy |
|
|||||
|
2015
Q1 | $14.5M | Buy |
|
|||||
|
2014
Q4 | $12.8M | Buy |
|
|||||
|
2014
Q3 | $8.74M | Sell |
|
|||||
|
2014
Q2 | $10.3M | Sell |
|
|||||
|
2014
Q1 | $16.9M | Sell |
|
|||||
|
2013
Q4 | $16.4M | Sell |
|
|||||
|
2013
Q3 | $16.4M | Buy |
|
|||||
|
2013
Q2 | $7.52M | Buy |
|